Clinical Trial Update: Selinexor, Cyclophosphamide and Prednisone in Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selinexor in combination with cyclophosphamide and prednisone for relapsed or refractory multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PREDNISONE (Prednisone)
• Selinexor (selinexor)

Snippet

Sponsor: University of Leeds | Conditions: Relapsed or Refractory Multiple Myeloma | Phase 2 | Status: COMPLETED